Idarubicin-bromelain combination sensitizes cancer cells to conventional chemotherapy
<em><strong>Objective(s):</strong> </em>The primary cytotoxic effects of anticancer drugs like idarubicin, a chemotherapeutic agent, are not limited to neoplastic cells; they also produce similar effects in normal cells. In this study, we hypothesized that the combination of...
Main Authors: | Abdullah Taşkın, Mehmet Tarakçıoğlu, Hasan Ulusal, Mustafa Örkmez, Seyithan Taysi |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2019-10-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | http://ijbms.mums.ac.ir/article_13602_ad87db01b810c1dadeca260d87a4a00e.pdf |
Similar Items
-
Idarubicin versus Doxorubicin in Acute Myeloid Leukemia: A Parallel Randomized Trial with Pharmacoeconomic Analysis
by: Amany El Zeiny, et al.
Published: (2024-01-01) -
Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis
by: Wenzhe Fan, et al.
Published: (2023-01-01) -
Optimal Conditions for Bromelain Extraction from Pineapple Fruit (Ananas comosus)
by: Ali J. R. AL-Sa, et al.
Published: (2016-05-01) -
Dose Dependent Biological Effects of Idarubicin in HL-60 Cells: Alterations of the Cell-Cycle and Apoptosis
by: Martina Mareková, et al.
Published: (2000-01-01) -
Electrochemical Sensing of Idarubicin—DNA Interaction Using Electropolymerized Azure B and Methylene Blue Mediation
by: Anastasia Goida, et al.
Published: (2022-01-01)